These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5945620)

  • 1. Effect of cholestyramine administration on serum lipids and on nitrogen balance in familial hypercholesterolemia.
    Howard RP; Brusco OJ; Furman RH
    J Lab Clin Med; 1966 Jul; 68(1):12-20. PubMed ID: 5945620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins].
    Vaverková H; Kubasta M; Zmeskal A; Procházka J; Vrublowský P; Podivínský
    Vnitr Lek; 1976 Jan; 22(1):73-83. PubMed ID: 175564
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.
    Glueck CJ; Fallat R; Tsang R
    Pediatrics; 1973 Nov; 52(5):669-79. PubMed ID: 4355362
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipoprotein lipid alterations with cholestyramine administration.
    Jones RJ; Dobrilovic L
    J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of cholestyramine in treatment of children with familial hypercholesterolaemia.
    West RJ; Lloyd JK
    Arch Dis Child; 1973 May; 48(5):370-4. PubMed ID: 4703066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of essential hyperlipidaemia.
    Jepson EM; Fahmy MF; Torrens PE; Billimoria JD; Maclagan NF
    Lancet; 1969 Dec; 2(7634):1315-9. PubMed ID: 4188089
    [No Abstract]   [Full Text] [Related]  

  • 10. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of cholestyramine on blood lipids].
    Giannini SD; Forti NA; Timoner M; Campanari JC
    Arq Bras Cardiol; 1977 Aug; 30(4):293-6. PubMed ID: 603433
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of action of cholestyramine in the treatment of hypercholesterolemia.
    Nazir DJ; Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1972 Jul; 46(1):95-102. PubMed ID: 5039828
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholestyramine therapy in patients homozygous for familial hypercholesterolemia (familial hypercholesterolemic xanthomatosis).
    Khachadurian AK
    J Atheroscler Res; 1968; 8(1):177-88. PubMed ID: 5642101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological treatment of hyperlipoproteinemias--theory and practice].
    Frisk-Holmberg M
    Lakartidningen; 1974 Aug; 71(34):3083-6. PubMed ID: 4410383
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum-lipid reducing principles--possibilities for treatment. 7. Ion exchangers (cholestyramine)].
    Nikkilä EA
    Lakartidningen; 1970 Dec; 67():Suppl IV:83+. PubMed ID: 5511955
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and therapy of symptomatic and essential hyperlipidemia].
    Dabels J
    Z Gesamte Inn Med; 1971 Apr; 26(8):261-5. PubMed ID: 5565821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of hyperlipoidaemias].
    Wolfram G
    Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of children with familial hypercholesterolaemia.
    West RJ; Fosbrooke AS; Lloyd JK
    Postgrad Med J; 1975; 51(8):82-7. PubMed ID: 768952
    [No Abstract]   [Full Text] [Related]  

  • 19. The pediatrician's role in genetic hyperlipidemias.
    Schleman MM
    Del Med J; 1981 Sep; 53(9):473-4. PubMed ID: 7338289
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
    Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.